Invivyd

We are thrilled to welcome Ajay Royan to our Board of Directors. Mr. Royan is the Managing General Partner and Co-Founder of Mithril Capital. Ajay’s commitment to mission and impressive track record will be invaluable as we optimize and advance monoclonal antibody therapies for COVID-19 and other serious viral infectious diseases. Please read the press release for more information.?https://lnkd.in/eGM9TFy4

We are excited to attend the Specialty Networks National Conference. We are looking forward to meeting members of the rheumatology community. We will be at booth #10. Stop by and say hello! #covid #rheumatology

Five years ago today, the WHO declared COVID-19 a pandemic. Since then, much of the world has moved on—but COVID hasn’t disappeared. People are still getting sick, hospitals still see surges, and Long COVID continues to disrupt lives. The good news? We still have the power to protect ourselves and our communities. Read our latest blog on why prevention still matters: https://lnkd.in/gdWqatxm #COVID19 #LongCOVID #PublicHealth #MaskUp #CleanAir

Today marks the 5th anniversary of the World Health Organization's declaration of COVID-19 as a pandemic. Many Americans have moved on from the fear they felt when the pandemic was declared in 2020, but still today, COVID-19 feels incredibly scary and isolating for many of the nearly 9 million Americans who are immunocompromised and living with, for example, cancer, organ transplant recipients, those on B cell depletion therapies or other immunosuppressive therapies. Five years later, these individuals shouldn’t have to choose between the potentially devastating impacts of COVID-19 and participation in daily life. Today, we honor and remember the lives lost to COVID-19, stand with those still being impacted, and remain dedicated to advancing medicines for serious viral infectious diseases. #covid #covid19

Happy International Women's Day from all of us at Invivyd! Today, we honor all of the incredible women around the world for driving progress and creating meaningful change in healthcare, science, and technology for the health and well-being of patients. #IWD2025 #AccelerateAction

We are thrilled to be at Controversies in Transplantation 2025! Stop by our exhibit right outside the main entrance to the ballroom to say hello!

#BreakingNews We are pleased to share that pemivibart shows continued neutralizing activity against LP.8.1, the currently dominant SARS-CoV-2 variant. #covid19

On Rare Disease Day, we are united in recognizing the 300 million people worldwide living with rare diseases, many of whom may be immunocompromised and vulnerable to serious viral infections like COVID-19.?#rarediseaseday

We are excited to be in Scottsdale, AZ to attend the Cutting Edge of Transplantation 2025 Transplant Summit. We look forward to meeting members of the transplant community! #CEoT2025 #OrganDonation #donatelife

Reminder! In partnership with National Infusion Center Association (NICA), join us TODAY at 12:00 PM Central for an insightful webinar exploring the persistent impact of COVID-19 and the evolving challenges posed by the SARs-CoV-2 virus. Registration is still open: https://lnkd.in/eqTHQZYh Gain a deeper understanding of the virus's ongoing evolution and its implications for healthcare providers, ensuring you stay informed and prepared to support vulnerable patients in your infusion practice.